Role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder: A narrative review

• Published in: Medicine (Baltimore) 2023-04, Vol.102 (14), p.e33477-e33477
• Main Author: Shen, Yingjing
• Format: Article
• Language: English
• Subjects: Bone Diseases, Metabolic - complications; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy; Chronic Kidney Disease-Mineral and Bone Disorder - etiology; Humans; Narrative Review; Parathyroid Hormone; Renal Insufficiency, Chronic; Uremia - complications; Vascular Calcification - complications; Vitamin D - therapeutic use; Vitamins - therapeutic use
• ISSN: 0025-7974; 1536-5964; 1536-5964
• DOI: 10.1097/MD.0000000000033477

Chronic kidney disease-mineral and bone disorder has complex and diverse clinical manifestations, including the simplest abnormalities of calcium, phosphorus and parathyroid hormone detected in blood, abnormalities of bone transformation and mineralization in bone, and calcification of blood vessels or other soft tissues detected on imaging. Patients with CKD-MBD combined low bone mineral density and fragility fractures are referred to as CKD-MBD with low bone mineral density. Vascular calcification refers to ectopic deposition of calcium phosphate in the blood vessel walls and heart valves. The degree of vascular calcification was inversely proportional to bone mineral density. The more severe the degree of vascular calcification, the lower the bone mineral density, and the higher the risk of death, indicating that the bone-vascular axis exists. Activation and alteration of the Wnt signaling pathway are central to the treatment of vascular diseases in uremia. Vitamin D supplementation can prevent secondary hyperparathyroidism, activate osteoblasts, relieve muscle weakness and myalgia, and reduce vascular calcification. Nutritional vitamin D may improve vascular calcification in uremia patients by regulating Wnt signaling pathway.